Skip to main content
. 2013 Jun 30;3(1):1–6. doi: 10.14581/jer.13001

Table 5.

Comparison between OXC treatment once daily and twice daily over time (n=13)

Once daily (n=4)
Twice daily (n=9)
p-value
Baseline 6 mon Baseline 6 mon
Seizure frequency 0.4±0.4 0.4±0.6 1.0±0.8 0.8±0.7 NS
Seizure freedom 2 (50%) 5 (56%) NS
Reduction > 50% 1 (25%) 1 (11%)* p>0.05
Spike index
  Left 27.6±26.5 33.0±19.2 12.8±15.8 22.8±18.1* p>0.05
  Right 21.0±27.1 24.7±24.0 13.0±13.0 16.3±16.8 NS
EEG (-) 0 (0%) 1 (11%) NS
FIQ 94.8±10.8 98.0±10.0 95.8±11.0 97.4±9.1 NS
VIQ 105.3±12.5 92.0±7.1 98.1±10.4 91.8±10.1 NS
PIQ 92.5±14.7 104.5±9.2 96.8±10.6 103.6±6.1 NS
Aggression 38.0±11.5 31.0±11.3 46.4±11.6 50.8±15.58* p>0.05

p values based on two way repeated measures, ANOVA.

FIQ, Full-scale intelligence quotient; VIQ, Verbal intelligence quotient; PIQ, Performance intelligence quotient; NS, Not significant statistically.

*

p<0.05.

EEG (-), normalization of sleep EEG.

Aggression, aggression on K-CBCL.